Reformulary Group announces Cannabis Standard, Canada’s first evidence-based medical cannabis formulary

X

Latest From the
world of Reformulary

Stevenson: OHIP+ changes the right prescription
 
Learn More
Focus on Delivering Value with Helen Stevenson
 
Learn More
School repairs, medication, cave rescue and Brexit
 
Learn More
Eight founders who are challenging the notion that tech is a man’s world
 
Learn More
Medicinal Cannabis
 
Learn More
CATA awards gala honours made-in-Ottawa artificial intelligence
 
Learn More
Reformulary Group to develop cannabis formulary
 
Learn More
Did commons committee get it right on pharmacare?
 
Learn More
Radio interview : CHED Morning News
 
Learn More
Voice technology helps Canadians compare clinical and cost-effectiveness of drugs
 
Learn More
How To Achieve National Pharmacare
 
Learn More
Reformulary Group introduces Alexa for DrugFinder
 
Learn More